Point72 Asset Management's 6.7% Stake in KALA BIO, Inc.

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G indicating a 6.7% ownership stake in KALA BIO, Inc. The filing, dated September 11, 2025, reports that Point72 Asset Management maintains investment and voting power over the shares held by Point72 Associates, LLC. Point72 Capital Advisors, Inc. is the general partner of Point72 Asset Management, and Steven A. Cohen controls both entities. The shares are held for investment purposes, and the filing includes a Joint Filing Agreement as Exhibit 99.1.